Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites.

[1]  F. Lucht,et al.  Primary physicians’ attitudes toward their patients receiving a proposal to participate in a vaccine trial , 2019, Human vaccines & immunotherapeutics.

[2]  John-Arne Røttingen,et al.  Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study , 2018, The Lancet Global Health.

[3]  Edith Jasny,et al.  New Vaccine Technologies to Combat Outbreak Situations , 2018, Front. Immunol..

[4]  N. Rouphael,et al.  Willingness to Participate in Vaccine-Related Clinical Trials among Older Adults , 2018, International journal of environmental research and public health.

[5]  F. Lucht,et al.  Vaccines for healthcare-associated infections: present, future, and expectations , 2018, Expert review of vaccines.

[6]  P. van Damme,et al.  Recruitment barriers for prophylactic vaccine trials: A study in Belgium. , 2017, Vaccine.

[7]  P. Souverein,et al.  Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands. , 2017, Journal of clinical epidemiology.

[8]  M. Stockwell,et al.  Factors associated with willingness to participate in a vaccine clinical trial among elderly Hispanic patients , 2017, Contemporary clinical trials communications.

[9]  F. Lucht,et al.  Barriers and motivations to volunteers’ participation in preventive vaccine trials: a systematic review , 2017, Expert review of vaccines.

[10]  Iain G. Johnston,et al.  The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey , 2016, EBioMedicine.

[11]  Joni K. Snyder,et al.  Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial , 2016, Clinical trials.

[12]  A. Kesselheim,et al.  Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size Companies. , 2016, Health affairs.

[13]  N. Sevdalis,et al.  Attitudes to vaccination: a critical review. , 2014, Social science & medicine.

[14]  D. Singer,et al.  Public Interest in Medical Research Participation: Differences by Volunteer Status and Study Type , 2014, Clinical and translational science.

[15]  Verena Schadewaldt,et al.  Clinical trial recruitment--a complex intervention? , 2013, Journal of clinical nursing.

[16]  G. Chapman,et al.  The influence of altruism on influenza vaccination decisions , 2012, Journal of The Royal Society Interface.

[17]  J. Bayas,et al.  Motivations for participating in a clinical trial on an avian influenza vaccine , 2012, Trials.

[18]  C. Logie,et al.  "Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown. , 2011, American journal of public health.

[19]  P Sojka,et al.  The blood donation experience: self‐reported motives and obstacles for donating blood , 2007, Vox sanguinis.

[20]  Claire Snowdon,et al.  Does it matter if clinicians recruiting for a trial don't understand what the trial is really about? Qualitative study of surgeons' experiences of participation in a pragmatic multi-centre RCT , 2007, Trials.

[21]  E. Vittinghoff,et al.  Determinants of Enrollment in a Preventive HIV Vaccine Trial: Hypothetical Versus Actual Willingness and Barriers to Participation , 2004, Journal of acquired immune deficiency syndromes.

[22]  N. Muñoz,et al.  Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. , 2001, Archives of medical research.

[23]  R. Prescott,et al.  Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.

[24]  Cowan Ervine.  Directive 2004/39/Ec of the European Parliament and of the Council of 21 April 2004 , 2015 .